598 related articles for article (PubMed ID: 35216231)
41. The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis.
Li HJ; Wu NL; Lee GA; Hung CF
Sci Rep; 2018 Apr; 8(1):6335. PubMed ID: 29679037
[TBL] [Abstract][Full Text] [Related]
42. Tanshinone IIA, a component of the self-made Xiao-Yin decoction, ameliorates psoriasis by inhibiting IL-17/IL-23 and PTGS2/NF-κB/AP-1 pathways.
Fu L; Li M; Wang P; Chen L; Huang J; Zhang H
Skin Res Technol; 2024 Feb; 30(2):e13577. PubMed ID: 38284293
[TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory, anti-proliferative and anti-psoriatic potential of apigenin in RAW 264.7 cells, HaCaT cells and psoriasis like dermatitis in BALB/c mice.
Singh VK; Sahoo D; Agrahari K; Khan A; Mukhopadhyay P; Chanda D; Yadav NP
Life Sci; 2023 Sep; 328():121909. PubMed ID: 37414141
[TBL] [Abstract][Full Text] [Related]
44. Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.
Wu Y; Chen X; Ge X; Xia H; Wang Y; Su S; Li W; Yang T; Wei M; Zhang H; Gou L; Li J; Jiang X; Yang J
J Mol Med (Berl); 2016 Feb; 94(2):195-206. PubMed ID: 26383911
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation.
Weng JR; Huang TH; Lin ZC; Alalaiwe A; Fang JY
Biomed Pharmacother; 2019 Nov; 119():109398. PubMed ID: 31493747
[TBL] [Abstract][Full Text] [Related]
46. The Essential Oil Derived from
Xu Y; Shi Y; Huang J; Gu H; Li C; Zhang L; Liu G; Zhou W; Du Z
Molecules; 2022 May; 27(9):. PubMed ID: 35566346
[TBL] [Abstract][Full Text] [Related]
47. Secoemestrin C Ameliorates Psoriasis-like Skin Inflammation in Mice by Suppressing the TNF-α/NF-κB Signaling Pathway.
Zhu ZB; Liu MJ; Wang J; Shu Z; Cao J
Curr Med Sci; 2024 Feb; 44(1):232-240. PubMed ID: 38393530
[TBL] [Abstract][Full Text] [Related]
48. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
[TBL] [Abstract][Full Text] [Related]
49. The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.
Chorachoo J; Lambert S; Furnholm T; Roberts L; Reingold L; Auepemkiate S; Voravuthikunchai SP; Johnston A
PLoS One; 2018; 13(10):e0205340. PubMed ID: 30321197
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model.
Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L
Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639
[TBL] [Abstract][Full Text] [Related]
51. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
52. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
[TBL] [Abstract][Full Text] [Related]
53. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.
Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R
Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853
[TBL] [Abstract][Full Text] [Related]
54. PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
Antal D; Pór Á; Kovács I; Dull K; Póliska S; Ujlaki G; Demény MÁ; Szöllősi AG; Kiss B; Szegedi A; Bai P; Szántó M
J Mol Med (Berl); 2023 Aug; 101(8):987-999. PubMed ID: 37351597
[TBL] [Abstract][Full Text] [Related]
55. Luteolin attenuates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via suppression of inflammation response.
Zhou W; Hu M; Zang X; Liu Q; Du J; Hu J; Zhang L; Du Z; Xiang Z
Biomed Pharmacother; 2020 Nov; 131():110696. PubMed ID: 32920513
[TBL] [Abstract][Full Text] [Related]
56. Antioxidant activity and inhibition of ultraviolet radiation-induced skin damage of Selenium-rich peptide fraction from selenium-rich yeast protein hydrolysate.
Guo H; Guo S; Liu H
Bioorg Chem; 2020 Dec; 105():104431. PubMed ID: 33161251
[TBL] [Abstract][Full Text] [Related]
57. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
[TBL] [Abstract][Full Text] [Related]
58. Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
Liu A; Zhang B; Zhao W; Tu Y; Wang Q; Li J
Bioengineered; 2021 Dec; 12(1):183-195. PubMed ID: 33323018
[TBL] [Abstract][Full Text] [Related]
59. NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside.
Zhan ZY; Jiang M; Zhang ZH; An YM; Wang XY; Wu YL; Nan JX; Lian LH
Phytomedicine; 2024 Aug; 131():155783. PubMed ID: 38838402
[TBL] [Abstract][Full Text] [Related]
60. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.
An J; Li Z; Dong Y; Ren J; Huo J
Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
